| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, |
| Model Number: | 99011-02-6 |
| Minimum Order Quantity: | 1 KG |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 99011-02-6 | Apparence: | White Crystalline Powder |
|---|---|---|---|
| Purity: | 98% | Stock: | Enough Stock |
| Packing: | As Your Requirement. | Stability: | Stable. Moisture-sensitive. |
| High Light: | chemical raw material,medical raw material |
||
Imiquimod Aldara Raw Material Powder CAS 99011-02-6 Cefmetazole R-837
Quick detail
Product Name: Imiquimod
Synonyms: R-837;S-26308;1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE;4-amino- 1-isobutyl-1h-imidazo[4,5-c]quinoline;ALDARA;IMIQUIMOD;1-isoButyl-1H-Inudazole[4.5-c]quinoline-4-amine;1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, R-837, S-26308, Aldara
CAS: 99011-02-6
MF: C14H16N4
MW: 240.3
EINECS: 1592732-453-0
Product Categories: Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Pharmaceuticals;ALDARA;Other APIs;Furans ,Coumarins
Description
An immune response modifier. It stimulates the production of interferon-a.
Imiquimod is a kind of imidozoquinoline amine-class interleukin agonist developed by the 3M Pharmaceuticals Company (US), belonging to the drug for the treatment of genital warts. Upon being applied to the mice skin, it can induce the cytokinesis and produce α-interferon, tumor necrosis factor and many kinds of interleukins. Clinically it can be used as the immunomodulators in the treatment of adult genital and perianal warts with convenient application, well tolerance and unique mechanism of action which makes it be the first-choice drug for treatment of genital warts.
Quality Index
| Item | Standard | Result |
| Appearance | White crystalline powder | White crystalline powder |
| Melting point | 289-294℃ | 291-293℃ |
| Feature identification | IR | Meet standard |
| Purity | ≥98.5% | 99.2% |
| Heavy metal | ≤10ppm | ≤10ppm |
| Drying loss | ≤1.0% | ≤1.0% |
| Ignition residue | ≤0.1% | ≤0.1% |
| Conclusion: meet standard | ||
Usage
| Uses | It can be used for anti-genital warts and as immunomodulators |
| Uses | It can be used for the treatment of adult external genital and perianal genital warts at 3 times per week. Just before sleep, first apply the product evenly in a thin layer on the surface of the wart and gently massage until the product is completely absorbed. |
| Uses | An immune response modifier. It stimulates the production of interferon-a |
| Uses | immunomodulator |
| Uses | raw material for Latamoxef, Cefminox, Ceftizoxime, Cefoxitin, Cefmetazole |
Dosage
The position of the medication should not be packeted and should be maintained for 6 to 10 hours, and then wash with a neutral soap and clean water for clearing the drugs in the administration site. Wash your hands before and after treatment. 250 mg of cream can be applied to 20cm2 of wart. Avoid excessive application of the drug. Patients should continue the treatment until the wart is completely cleared. Wart can be cleared within 2-4 week at the fastest speed and can be generally cleared within 8 to 12 weeks. The medication should be not more than 16 weeks.
After the treatment, patients with mild erythema locally who does not have to be discontinued for drug; if the patients feel general malaise or get local skin reactions (edema, erosion, pain, etc.), the drug should be discontinued. Only when the reaction is alleviated can they continue the medication.
Safety Info
| Safety Statements: | S26-S27-S36/37/39-S45 |
| HS Code: | 2933990090 |
| RIDADR: | UN 2811 6.1/PG 3 |
| Risk Statements: | R25; R36/37/38 |
| Hazard Codes: | T; Xi |
